Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases.
Theradiag are the market leaders in Therapeutic Drug Monitoring (TDM) with assays validated and supported by the pharmaceutical industry.
Theradiag IMMUNO-TROL Quality Controls are unassayed non-kit controls. This means that the controls do not have values or reference ranges assigned by the manufacturer.
Registration is now open for the Allergy & Autoimmune User Group Meeting.
The Theradiag FIDIS™ Multiplexing assays utilise Luminex® xMAP technology to simultaneously detect multiple autoantibodies in a single well.